Evidence map›Paper›PMID 37656930›Full record

Trial reportJournal of clinical oncology : official journal of the American Society of Clinical Oncology2023

Randomized Trial of Exercise and Nutrition on Chemotherapy Completion and Pathologic Complete Response in Women With Breast Cancer: The Lifestyle, Exercise, and Nutrition Early After Diagnosis Study.

Tara Sanft, Maura Harrigan, Courtney McGowan, Brenda Cartmel, Michelle Zupa, Fang-Yong Li, Leah M Ferrucci, Leah Puklin, Anlan Cao, Thai Hien Nguyen and 10 more

3 registry-linked trialsOpen access · hybridAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 3 registered trials, which are not on this map. Cited by 60 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
60citing papers in PubMed, 5 pooled it
18.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06429189 naunknown statusnot on this mapstarted 2024, after this paper: background citation

An Online Home-based Combined Exercise Intervention With Self-selected Intensity for Women With Breast Cancer: The Home-Combo Randomized Controlled Trial.

TypeinterventionalSponsorGrupo LusófonaRan2024 to 2025Enrolled98ConditionsBreast Cancer, Chemotherapy EffectArmsHome-based combined exercise program with self-selected intensity
NCT06497322 nanot yet recruitingnot on this mapstarted 2024, after this paper: background citation

Effectiveness of High-intensity Interval Training During Neoadjuvant Immunochemotherapy on Complete Remission in Patients With Triple-negative Breast Cancer

TypeinterventionalSponsorUniversity Hospital of CologneRan2024 to 2027Enrolled60ConditionsBreast Cancer, Triple Negative Breast CancerArmsExercise intervention - High intensity interval training on a cycle-ergometer
NCT07502963 nanot yet recruitingnot on this mapstarted 2026, after this paper: background citation

Effectiveness of a Multimodal Outpatient Supervised Physical Activity Program to Improve Tolerance and Efficacy of Chemotherapy in Adults With Breast, Lung and Colon Cancer: Randomized Clinical Trial.

TypeinterventionalSponsorUniversity of Vic - Central University of CataloniaRan2026 to 2027Enrolled70ConditionsBreast Cancer, Lung Cancer (Non-Small Cell), Colorectal Cancer, Physical ActivityArmsPREDU Exercise Program, Recommendation Exercise Program
3 · Its place in the literature

Who cites it

60 citing papers in PubMed, 5 syntheses or guidelines pooled it, 79 citations in OpenAlex.

  1. Exercise and pathologic complete response to cancer treatment: a systematic review and meta-analysis.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2026
    Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Trial
  7. Trial
  8. Trial
  9. Evaluation of physical rehabilitation in patients receiving curative treatment for head and neck cancer: The NUTRIMOUV randomized phase II trial.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2025
    Trial
  10. Trial
  11. Trial
  12. Trial
  13. Trial
  14. Exploring the effect of exercise training on breast cancer's pathologic response and tumor immune microenvironment after neoadjuvant chemotherapy.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2024
    Trial
  15. Trial
  16. Exercise therapy in cancer prevention and treatment.Nature reviews. Clinical oncology · 2026
    Review
  17. Article
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 6 institutions in 1 country.

Tara SanftYale University School of Medicine, New Haven, CT.ORCID 0000-0002-1687-2538
Maura HarriganYale School of Public Health, New Haven, CT.
Courtney McGowanYale School of Public Health, New Haven, CT.
Brenda CartmelYale Cancer Center, New Haven, CT.ORCID 0000-0002-4748-5143
Michelle ZupaYale School of Public Health, New Haven, CT.ORCID 0000-0002-0897-4833
Fang-Yong LiYale School of Public Health, New Haven, CT.ORCID 0000-0003-3171-7592
Leah M FerrucciYale Cancer Center, New Haven, CT.ORCID 0000-0001-9488-7586
Leah PuklinYale School of Public Health, New Haven, CT.ORCID 0000-0003-0848-4866
Anlan CaoYale School of Public Health, New Haven, CT.ORCID 0000-0001-7190-657X
Thai Hien NguyenYale School of Public Health, New Haven, CT.
Marian L NeuhouserFred Hutchinson Cancer Research Center, Seattle, WA.
Dawn L HershmanColumbia University Medical Center, New York, NY.ORCID 0000-0001-8807-153X
Karen Basen-EngquistThe University of Texas MD Anderson Cancer Center, Houston, TX.ORCID 0000-0001-7299-0646
Beth A JonesYale Cancer Center, New Haven, CT.
Tish KnobfYale Cancer Center, New Haven, CT.
Anees B ChagparYale University School of Medicine, New Haven, CT.ORCID 0000-0001-7641-4443
Andrea SilberYale University School of Medicine, New Haven, CT.ORCID 0000-0002-3339-6959
Anna TanasijevicDana-Farber Cancer Institute, Boston, MA.
Jennifer A LigibelDana-Farber Cancer Institute, Boston, MA.ORCID 0000-0002-0633-3151
Melinda L IrwinYale Cancer Center, New Haven, CT.ORCID 0000-0001-7571-0304
Yale Cancer Center · USYale University · USDana-Farber Cancer Institute · USColumbia University Irving Medical Center · USFred Hutch Cancer Center · USThe University of Texas MD Anderson Cancer Center · US

Funding

Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9M
A randomized trial of lifestyle guidelines on breast cancer biomarkers and treatment adherenceR01CA207753 · NCI · YALE UNIVERSITY · PI IRWIN, MELINDA L, SANFT, TARA B · 2017 to 2021
$3.5M
NCATS NIH HHS UL1 TR001863NCI NIH HHS R01 CA207753
6 · The paper itself

Abstract

purposeSuccessful completion of chemotherapy is critical to improve breast cancer outcomes. Relative dose intensity (RDI), defined as the ratio of chemotherapy delivered to prescribed, is a measure of chemotherapy completion and is associated with cancer mortality. The effect of exercise and eating a healthy diet on RDI is unknown. We conducted a randomized trial of an exercise and nutrition intervention on RDI and pathologic complete response (pCR) in women diagnosed with breast cancer initiating chemotherapy.

methodsOne hundred seventy-three women with stage I-III breast cancer were randomly assigned to usual care (UC; n = 86) or a home-based exercise and nutrition intervention with counseling sessions delivered by oncology-certified registered dietitians (n = 87). Chemotherapy dose adjustments and delays and pCR were abstracted from electronic medical records. T-tests and chi-square tests were used to examine the effect of the intervention versus UC on RDI and pCR.

resultsParticipants randomly assigned to intervention had greater improvements in exercise and diet quality compared with UC (

conclusionAlthough a diet and exercise intervention did not affect RDI, the intervention was associated with a higher pCR in patients with hormone receptor-positive/human epidermal growth factor receptor 2-negative and triple-negative breast cancer undergoing neoadjuvant chemotherapy.

Indexed as

Breast NeoplasmsTriple Negative Breast NeoplasmsDietExerciseFemaleHumansLife StyleNutritional Status

Identifiers

PMID37656930
PMCPMC10691793
OpenAlexW4386356153

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.